Latest Proteins biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

New pathway to treat a rare and aggressive liver cancer: Blocking CNNM4 protein with RNA technology

by CIC bioGUNE

10 months ago
cholangiocarcinoma (CCA), CNNM4 protein, GalNAc siRNA technology

The findings suggest that inhibiting CNNM4, combined with GalNAc siRNA technology, could offer a targeted, safe, and effective treatment, opening new avenues for personalized therapies against this ag...

VarmX partners with CSL in a strategic collaboration and option agreement to develop novel investigational coagulation treatment

by Ysios Capital

10 months ago
coagulation, VarmX partners, CSL, VMX-C001, anticoagulants targeting activated factor Xa (FXa DOACs)

Financiación completa del ensayo de fase III del VMX-C001, desarrollo del producto en fase avanzada, fabricación y actividades previas al lanzamiento.

An Aragonese study suggests that a milk protein could have intestinal benefits.

by Universidad de Zaragoza

10 months ago
lactoferrin, intestinal inflammation, serotonin

The results obtained support the thesis that lactoferrin protects against intestinal inflammation by modulating serotonin.

ARTHEx Biotech Upsizes Series B Financing Round to $87 millones

by ARTHEx Biotech

10 months ago
ATX-01, Myotonic Dystrophy Type 1 (DM1), ArthemiRTM, MBNL protein, toxic DMPK mRNA, microRNA23b (miR-23b), ARTHEx Biotech

Proceeds to support further clinical development of lead program ATX-01 in Myotonic Dystrophy Type1, a unique therapy currently in Phase I-IIa, targeting miR23b

New genetic clock mechanism discovered in plant roots

by Centro de Biotecnología y Genómica de Plantas CBGP

10 months ago
organogenesis, G1 phase, PLETHORA (PLT) genes, RETINOBLASTOMA-RELATED1 (RBR1) and KIP-RELATED PROTEIN 5 (KRP5) proteins

An international team led by the CBM in collaboration with CBGP has discovered that plant roots have an "internal clock" that governs when and how cells divide. This discovery explains how plants coor...

Investigadores de la UPO identifican un antioxidante como posible tratamiento para la ataxia de Friedreich, una severa enfermedad neurodegenerativa

by Universidad Pablo de Olavide, de Sevilla

10 months ago
ácido alfa-lipoico (ALA), ataxia de Friedreich (FRDA), frataxina, expansión de tripletes

El ácido alfa-lipoico (ALA) puede restaurar los niveles de frataxina y tener un impacto beneficioso en la función mitocondrial en modelos celulares derivados de pacientes con ataxia de Friedreich (F...

Una investigación del CSIC propone una nueva vía para tratar un cáncer de hígado muy agresivo

by CSIC - Centro Superior de Investigaciones Científicas

El estudio sugiere actuar sobre el entorno del tumor, como alternativa a los tratamientos actuales que atacan directamente a las células tumorales

New findings explain how a mutation in a cancer-related gen causes pulmonary fibrosis

by CNIO - Centro Nacional de Investigaciones Oncológicas

10 months ago
POT1 gene, Idiopathic pulmonary fibrosis, ‘telomere syndromes’, shelterins, Telomeres

A research group from the National Cancer Research Centre (CNIO) has found that an alteration in the POT1 gene prevents lung tissue from regenerating, which over time makes breathing difficult.

Parc Taulí will evaluate a new therapy for Angelman syndrome

by Instituto de Investigación e Innovación Parc Taulí

9 months ago
Angelman syndrome, antisense oligonucleotide (ASO), gene UBE3A

The center is participating in an international clinical trial that seeks to improve patients' quality of life by addressing sleep, communication and motor disorders.

Fetal Bovine Serum (FBS): A Key Reagent for Reliable Cell Culture

by Canvax Biotech

9 months ago
Fetal Bovine Serum

FBS provides the complex mixture of biomolecules necessary to support cell attachment, proliferation, and viability. Unlike defined synthetic alternatives, it offers a broad spectrum of macromolecules...

First evidence of a ‘nearly universal’ pharmacological chaperone for rare disease

by Centre for Genomic Regulation

9 months ago
vasopressin V2 receptor (V2R), nephrogenic diabetes insipidus (NDI), tolvaptan, G-protein-coupled receptors (GPCRs)

A study published today in Nature Structural & Molecular Biology is the first time researchers have shown evidence that a single drug, already licensed for medical use, can stabilise nearly all mutate...

Integrated DNA Technologies Launches New Enhancer Protein to Accelerate CRISPR-based Therapies from Translational Research to Clinical Breakthrough

by Integrated DNA Technologies

9 months ago
Alt-R™ HDR Enhancer Protein, Integrated DNA Technologies (IDT)

Research grade recombinant protein expands toolkit of available CRISPR nucleases and increases efficiency of homology-directed repair (HDR) to enable more precise genome modifications